《沪深两市》上证深成半日跌0.2%-0.8% 银行股弱势 汽车股逆市造好
美国总统特朗普政府禁止美国对部分中国企业作出投资。人行今日进行1,600亿元人民币7天期逆回购操作。上证深成双双低开後一度急跌，其後回顺，半日反覆偏软。
上证半日跌24点或0.8%，收报3,313点；深成跌21点或0.2%，收报13,770点；沪深300指数跌46点或1%，收报4,862点；创业板指数则升13点或0.5%，收报2,714点，成交1,109亿元。两市成交分别为1,891亿元及2,690亿元。
银行股走弱，建行(601939.SH)、工行(601398.SH)、国寿(601628.SH)跌0.8%-2.8%。平安银行(000001.SZ)、兴业银行(601166.SH)、宁波银行(002142.SZ)、杭州银行(600926.SH)、招商银行(600036.SH)跌1.6%-3.6%。
汽车股逆市造好，比亚迪(002594.SZ)扬5.6%。江淮汽车(600418.SH)、长城汽车(601633.SH)、金龙汽车(600686.SH)升2.3%-3.3%。锂电池股亦见造好，华友钴业(603799.SH)涨停。寒锐钴业(300618.SZ)、盛新锂能(002240.SZ)、盛屯矿业(600711.SH)、亿纬锂能(300014.SZ)升3.4%-7.5%。
白酒股显着回吐，口子窖(603589.SH)、伊力特(600197.SH)、迎驾贡酒(603198.SH)跌停。金徽酒(603919.SH)、今世缘(603369.SH)挫9.8%、8.6%。
部份半导体股表现向好，立昂微(605358.SH)涨停。斯达半导(603290.SH)、新洁能(605111.SH)、雅克科技(002409.SZ)、台基股份(300046.SZ)升3.5%-6.3%。中芯国际(688981.SH)升1%。惟紫光国微(002049.SZ)挫8.9%。
君实生物(688180.SH)产品及研发遭质疑正接受上交所问询，股价跌4.3%。复星医药(600196.SH)跌3.8%。复宏汉霖骨髓瘤药物临床试验申请获受理。
美国总统特朗普政府禁止美国对部份中国企业作出投资，据报受影响的可能包括大型企业如中国电信(00728.HK)、中国移动(00941.HK)及监控设备生产商海康威视(002415.SZ)。消息拖累海康威视跌1.3%。受负面消息拖累，中国联通(600050.SH)低开低走，股价半日跌1.2%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app！
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
